COMPANY

Oak Therapeutics Inc.

Oak Therapeutics' ODS has developed formulations that allow us to adjust the dissolution time of ODS from seconds to slow-release over multiple hours, and we can target delivery and absorption sites. From company website Source · Oct 12, 2026

Keywords:

Profile checked Oct 10, 2026

3NIH grants

Funding and NIH signals

NIH award NIH awarded $899K (SBIR Phase II 2R44AI170237-02A1, competing renewal, notice Aug 5, 2026); 2 NIH awards totaling $1.71M in the last 12 months. NIH RePORTER 2R44AI170237-02A1 (Aug 5, 2026)
Evidence (2 events)
- Aug 5, 2026 · NIH RePORTER 2R44AI170237-02A1
  Organization: OAK THERAPEUTICS, INC.; City/State: Lawrence, KS; Project number: 2R44AI170237-02A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-05; FY total cost (award amount): 899010; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Novel antiretroviral therapy delivery platform for infants and young children: oral dispensable strips (ODS); Organization type: Domestic For-Profits
- Jul 28, 2026 · NIH RePORTER 5R44AI179391-03
  Organization: OAK THERAPEUTICS, INC.; City/State: Lawrence, KS; Project number: 5R44AI179391-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-28; FY total cost (award amount): 814340; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Oral Dissolvable Strips (ODS) as new pediatric and adult delivery mode of therapy for latent tuberculosis; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Aug 5, 2026 Grant Government grant — SBIR: $899,010 (annual award, as published), announced Aug 5, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 28, 2026 Grant Government grant — SBIR: $814,340 (annual award, as published), announced Jul 28, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 14, 2025 Grant Government grant — SBIR: $892,787 (annual award, as published), announced Aug 14, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

Funding

Last 2 years.

Aug 5, 2026 Government grant — SBIR: $899,010 (annual award, as published), announced Aug 5, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Jul 28, 2026 Government grant — SBIR: $814,340 (annual award, as published), announced Jul 28, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Aug 14, 2025 Government grant — SBIR: $892,787 (annual award, as published), announced Aug 14, 2025. Agency: NIH/NIAID. Source: government award database. source ↗

NIH awards 3

Annual award amounts. Total $711K.

Aug 25, 2023 NIH award 1R43AI179391-01 FY2023: $273,458 awarded for that fiscal year; activity R43 (SBIR); PI MALISKI, EDWARD G; recipient as written: OAK THERAPEUTICS, INC., Lawrence, KS. Oral Dissolvable Strips (ODS) as new ped source ↗
Aug 26, 2022 NIH award 1R43AI170237-01 FY2022: $216,846 awarded for that fiscal year; activity R43 (SBIR); PI MALISKI, EDWARD G; recipient as written: OAK THERAPEUTICS, INC., Lawrence, KS. Novel antiretroviral therapy delivery pl source ↗
2016 NIH contract (government contract; not a grant and not an investment round) 272201600033C-0-0-1 FY2016: $220,582 awarded for that fiscal year; activity N01 (OTHER_NIH); PI BOBZIN, STEVE; recipient as written: OAK THERAPEUTICS, INC., Lawrence, KS. ORAL DISSOLVI source ↗